Evidence map›Paper›PMID 38847472›Full record

ArticleJournal of cellular and molecular medicine2024

Machine learning-based identification of a cell death-related signature associated with prognosis and immune infiltration in glioma.

Quanwei Zhou, Fei Wu, Wenlong Zhang, Youwei Guo, Xingjun Jiang, Xuejun Yan, Yiquan Ke

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Quanwei ZhouThe National Key Clinical Specialty, Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Fei WuThe National Key Clinical Specialty, Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Wenlong ZhangDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Youwei GuoDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Xingjun JiangDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Xuejun YanNHC Key Laboratory of Birth Defect for Research and Prevention, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, China.ORCID 0000-0001-8635-2979
Yiquan KeThe National Key Clinical Specialty, Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.ORCID 0000-0002-7356-8559

Funding

China Postdoctoral Science Foundation 2023M741587National Natural Science Foundation of China 81472355National Natural Science Foundation of China 82072762Natural Science Foundation of Hunan Province 2024JJ6262
6 · The paper itself

Abstract

Accumulating evidence suggests that a wide variety of cell deaths are deeply involved in cancer immunity. However, their roles in glioma have not been explored. We employed a logistic regression model with the shrinkage regularization operator (LASSO) Cox combined with seven machine learning algorithms to analyse the patterns of cell death (including cuproptosis, ferroptosis, pyroptosis, apoptosis and necrosis) in The Cancer Genome Atlas (TCGA) cohort. The performance of the nomogram was assessed through the use of receiver operating characteristic (ROC) curves and calibration curves. Cell-type identification was estimated by using the cell-type identification by estimating relative subsets of known RNA transcripts (CIBERSORT) and single sample gene set enrichment analysis methods. Hub genes associated with the prognostic model were screened through machine learning techniques. The expression pattern and clinical significance of MYD88 were investigated via immunohistochemistry (IHC). The cell death score represents an independent prognostic factor for poor outcomes in glioma patients and has a distinctly superior accuracy to that of 10 published signatures. The nomogram performed well in predicting outcomes according to time-dependent ROC and calibration plots. In addition, a high-risk score was significantly related to high expression of immune checkpoint molecules and dense infiltration of protumor cells, these findings were associated with a cell death-based prognostic model. Upregulated MYD88 expression was associated with malignant phenotypes and undesirable prognoses according to the IHC. Furthermore, high MYD88 expression was associated with poor clinical outcomes and was positively related to CD163, PD-L1 and vimentin expression in the in-horse cohort. The cell death score provides a precise stratification and immune status for glioma. MYD88 was found to be an outstanding representative that might play an important role in glioma.

Indexed as

Biomarkers, TumorGene Expression Regulation, NeoplasticGliomaMachine LearningNomogramsBrain NeoplasmsCell DeathFemaleGene Expression ProfilingHumansLymphocytes, Tumor-InfiltratingMaleMiddle AgedMyeloid Differentiation Factor 88PrognosisROC CurveBiomarkers, TumorMyeloid Differentiation Factor 88cell deathgliomaimmune infiltrationmachine learningprognosistumour microenvironment

Identifiers

PMID38847472
PMCPMC11157676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.